Genetic testing can identify inherited risks for some types of cancer. The results of these tests affect both you and your family. Here are some things to think about when sharing genetic test results.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
Donating bone marrow can be as easy and painless as giving blood. Here’s what you need to know about the life-saving tissue inside your bones and the current donation process.
Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month.
Thinking about taking an at-home genetic test? In this podcast, Dr. Nadine Tung provides her expert insight on the advantages and disadvantages of these tests.
Researchers are using genetic information to find a woman’s risk for breast cancer. Dr. Kurian writes about how this knowledge affects screening and prevention strategies for breast cancer.
Genetic testing allows doctors to help treat, and even prevent, certain types of cancers. Many patients can benefit from genetic testing; however, we still don’t know a lot about how to best use the results of these tests.
Identifying genetic changes has given us new insights in early detection and treatment of advanced and castration-resistant prostate cancer.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Some of those advances focus on improving the quality of care and patients’ access to it.
These studies from the ASCO Annual Meeting show some of the newest thoughts and latest advances in using immunotherapy and targeted therapy to treat bladder, stomach, and lung cancers.